Features
Law Firm Financial Impropriety
Funds can come up missing in any law firm, and the cause can be intentional theft that qualifies as fraud or embezzlement, or an unintentional mistake that shows poor judgment.
Features
Russian State Officials' Assets Abroad
Russian President Vladimir Putin has submitted two bills aimed at reducing public corruption by establishing various methods of control over the actions of public officials. Here's how this may affect U.S. companies doing business in Russia.
Navigating the FCPA in Healthcare and Life Sciences
It appears that the world of healthcare, pharmaceuticals, and medical devices will continue to figure prominently in FCPA enforcement. Here's why..
The Final Countdown
Regarding the Affordable Care Act, 2014 ushers in the most significant changes to date: the implementation of Health Benefit Exchanges (Exchanges) and employer "shared responsibility" provisions. Here's what you need to know.
Features
'Immediate and Appropriate Corrective Action'
Some employers may not be aware that their obligation to prevent harassment in the workplace extends to preventing harassment by non-employees, including, for example, customers, patients, and university students.
Features
How to Safely Navigate the New I-9 Minefield
Employers must use the latest version of Form I-9 bearing an edition date of March 8, 2013, and those that fail to do so may be subject to penalties enforced by Immigration and Customs Enforcement (ICE). Here's what you need to know.
Columns & Departments
Verdicts
An in-depth study of ruling of interest.
Columns & Departments
Drug & Device News
Review of the latest news.
Columns & Departments
Med Mal News
A look at several recent news items.
Features
Foreseeable Harm to Third Parties Keeps Claim Against Drug Makers Alive
Alabama's Supreme Court in January rendered a potentially far-reaching decision in a case pitting a consumer against drug manufacturers. While its holding applies only to cases brought in Alabama, the court's decision may lead to that state's becoming the preferred forum for certain types of drug litigation:
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- The Article 8 Opt InThe Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.Read More ›
- Warehouse Liability: Know Before You Stow!As consumers continue to shift purchasing and consumption habits in the aftermath of the pandemic, manufacturers are increasingly reliant on third-party logistics and warehousing to ensure their products timely reach the market.Read More ›
- Litigating Redesigns At the ITCAn overview of redesigns at the ITC, a discussion of the ITC's recent determination in Certain Audio Players and Controllers, and identifies some considerations to keep in mind when litigating redesigns at the ITC.Read More ›
- Applying Merger By Deed Doctrine to Real Estate TransactionsSince a deed is a subsequent writing between the parties, there is some logic to the terms of the deed taking precedence over the terms of the prior contract of sale, at least as to the subject matter of the deed.Read More ›